Viewing StudyNCT00089856



Ignite Creation Date: 2024-05-05 @ 11:36 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00089856
Status: TERMINATED
Last Update Posted: 2008-11-05
First Post: 2004-08-16

Brief Title: GVAX Vaccine for Prostate Cancer vs Docetaxel Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer
Sponsor: Cell Genesys
Organization: Cell Genesys

Conditions & Keywords Data

Conditions:
Name
Prostate Cancer
Keywords:
Name View
Advanced Prostate Cancer View
Prostate View
Cancer View
Metastatic View
Hormone-refractory View
GVAX View
Chemotherapy View
Taxotere View
Docetaxel View
Prednisone View
Vaccine View
Allogeneic cells View